Lemaitre Vascular (LMAT) Current Assets (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Current Assets of $477.8 million for Q1 2026, up 17.08% year-over-year from $408.1 million in Q1 2025, and up 2.05% quarter-over-quarter from $468.2 million in Q4 2025.
Lemaitre Vascular (LMAT) Current Assets (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Current Assets for 17 consecutive years, with $477.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 17.08% year-over-year to $477.8 million; the TTM figure through Mar 2026 stood at $477.8 million (up 17.08% YoY), while the FY2025 annual figure was $468.2 million, up 16.42% from the prior year.
- Current Assets grew to $477.8 million in Q1 2026 per LMAT's latest filing, from $468.2 million in the prior quarter.
- Across five years, Current Assets topped out at $477.8 million in Q1 2026 and bottomed at $141.4 million in Q1 2022.
- Historically, Current Assets has averaged $270.7 million across 5 years, with a median of $203.0 million in 2024.
- Annual changes were most pronounced in 2022 — Current Assets increased 14.27% — and 2024, when it surged 106.68%.
- Lemaitre Vascular's Current Assets stood at $161.7 million in 2022, then grew by 20.32% to $194.6 million in 2023, then jumped by 106.68% to $402.2 million in 2024, then gained by 16.42% to $468.2 million in 2025, then advanced by 2.05% to $477.8 million in 2026.
- Business Quant data shows LMAT's Current Assets at $477.8 million in Q1 2026, $468.2 million in Q4 2025, and $452.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 9.54 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 8.14 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 6.62 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 4.32 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 11.74 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 1.81 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.74 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 2.30 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.99 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 488.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 488.30 Mn |
| Mar 31, 2026 | 477.82 Mn |
| Dec 31, 2025 | 468.23 Mn |
| Sep 30, 2025 | 452.03 Mn |
| Jun 30, 2025 | 430.13 Mn |
| Mar 31, 2025 | 408.11 Mn |
| Dec 31, 2024 | 402.19 Mn |
| Sep 30, 2024 | 227.12 Mn |
| Jun 30, 2024 | 212.81 Mn |
| Mar 31, 2024 | 202.96 Mn |
| Dec 31, 2023 | 194.60 Mn |
| Sep 30, 2023 | 182.18 Mn |
| Jun 30, 2023 | 174.49 Mn |
| Mar 31, 2023 | 164.77 Mn |
| Dec 31, 2022 | 161.73 Mn |
| Sep 30, 2022 | 153.14 Mn |
| Jun 30, 2022 | 148.49 Mn |
| Mar 31, 2022 | 141.41 Mn |
| Dec 31, 2021 | 139.88 Mn |
| Sep 30, 2021 | 134.02 Mn |